# Gemina Laboratories Ltd. (GLABF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GLABF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 21.5K | $ -2.22M | $ -510.7K | $ 1.30M | $ -5.98M |
| 2024 | $ 0 | $ -4.07M | $ -1.30M | $ 1.27M | $ -4.44M |
| 2023 | $ 0 | $ -5.32M | $ -3.35M | $ 285.3K | $ -1.59M |
| 2022 | $ 0 | $ -6.20M | $ -4.76M | $ 240.8K | $ -71.8K |
| 2021 | $ -5.4K | $ -5.09M | $ -4.16M | $ 46.1K | $ 944.2K |
| 2020 | $ 0 | $ -1.27M | $ -493 | $ 98.1K | $ 160.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.22 |
| Liabilities / Eq | -1.27 |
| Current Ratio | 0.07 |

## Other views

- [Metrics](https://sponda.capital/en/GLABF.md)
- [Charts](https://sponda.capital/en/GLABF/charts.md)
- [Compare](https://sponda.capital/en/GLABF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.